September 2025

26 September 2025

Require Clinical Data Specialist at Medtronic

Collaborates with various departments on the design, documentation, testing, and implementation of clinical data collection studies, and clinical database review.

26 September 2025

Work as Forecasting Platform Specialist Associate at AstraZeneca

Forecast Platform Specialist works closely with the GCS Forecasting CoE/ GIBEx/ GA&I teams as well as the Platform vendor team in deploying the cloud-based forecasting platform.

26 September 2025

Apply Online for eTMF Operation Analyst at Bristol Myers Squibb

Utilizing an intellectually disciplined process of actively and skillfully conceptualizing, applying, analyzing, synthesizing and/or evaluating information gathered from, or generated by, experience, reasoning or communication that will be instrumental in the decision-making process for quality review.

26 September 2025

Alkem launches Pertuza, a pertuzumab biosimilar, in India

Alkem Laboratories Ltd. announced the launch of Pertuza injection 420mg/14mL, a pertuzumab biosimilar, in India for the treatment of HER2-positive breast cancer.

26 September 2025

Glenmark Strengthens Oncology Portfolio with Hengrui’s HER2 Targeting ADC For Multiple Regions

Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Ltd. (Glenmark), today announced that it has entered into an exclusive license and collaboration agreement with Hengrui Pharma for Trastuzumab Rezetecan (SHR-A1811), a next-generation HER2-targeting antibody drug conjugate (ADC).

26 September 2025

Lupin Receives Tentative Approval from USFDA for Bictegravir, Emtricitabine, and Tenofovir Alafenamide Tablets

Global pharma major Lupin Limited announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Bictegravir, Emtricitabine, and Tenofovir Alafenamide Tablets, 50 mg/200 mg/25 mg. This product would be manufactured at Lupin’s Nagpur facility in India.

26 September 2025

Unitaid, CHAI, and Wits RHI enter into a landmark agreement with Dr. Reddy’s to make HIV prevention tool lenacapavir affordable in LMICs

The revolutionary HIV prevention tool, injectable lenacapavir, will be available at a cost of USD 40 a year in 120 low- and middle-income countries starting in 2027, under a new partnership announced today between Dr. Reddy’s Laboratories and Unitaid, the Clinton Health Access Initiative (CHAI), and Wits RHI

26 September 2025

Systemically injectable therapy could prevent heart failure after a heart attack

Scientists at Northwestern University and University of California San Diego have developed a new, potent injectable therapy that can protect the heart from damage after a heart attack.

25 September 2025

Hiring Pharmacist under the Siddha Medical Department

D.Pharm / Integrated Pharmacy Course – under the Siddha Medical Department through the District Health Society on a lump sum basis.

25 September 2025

Openings for Pharma, Biotechnology, Bioinformatics at NCL for National Network Project

Master, Integrated Masters in Natural or Agricultural or Pharmaceutical Sciences, MVSc, Animal Sciences. Any equivalent qualifications duly recognized by the concerned authority as per the functional requirement.